Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Botti

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Journal of Biophotonics|September 17, 2015
Label-free and non-invasive discrimination of HaCaT and melanoma cells in a co-culture model by hyperspectral confocal reflectance microscopyFrancesca R Bertani, Elisabetta Botti, Luisa Ferrari, et al.
Drug Development Research|November 11, 2014
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerationsBarbara Marinari, Elisabetta Botti, Mauro Bavetta, et al.
Dermatology Practical & Conceptual|March 22, 2021
Usefulness of Topical Imiquimod 3.75% in Cytokeratin 7 Positive Extramammary Paget Disease of the Vulva: Towards Personalized TherapySara Mazzilli, Annunziata Dattola, Anna Angela Criscuolo, et al.
The Journal of International Medical Research|September 30, 2016
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritisMaria Sole Chimenti, Paola Triggianese, Elisabetta Botti, et al.
Journal of the American Academy of Dermatology|December 4, 2018
Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observationsRaffaele Dante Caposiena Caro, Maria Vittoria Cannizzaro, Elisabetta Botti, et al.
Italian Journal of Dermatology and Venereology|October 24, 2018
Long-term efficacy and safety of adalimumab on a severe case of hidradenitis suppurativaRaffaele D Caposiena Caro, Maria V Cannizzaro, Cosimo DI Raimondo, et al.
Immunology Letters|October 22, 2013
Genetic variations in IL6 and IL12B decreasing the risk for psoriasisAndreea Nicoleta Boca, Marina Talamonti, Marco Galluzzo, et al.
Health Science Reports|May 12, 2021
HLA-C*06:02 allele can influence clinical efficacy of certolizumab pegol?Annunziata Dattola, Elisabetta Botti, Marco Galluzzo, et al.
BMC Research Notes|December 19, 2014
Severe erytrodermic psoriasis in child twins: from clinical-pathological diagnosis to treatment of choice through genetic analyses: two case reportsElena Campione, Laura Diluvio, Alessandro Terrinoni, et al.
The Australasian Journal of Dermatology|October 11, 2020
Cutaneous mastocytosis: A dermatological perspectiveCosimo Di Raimondo, Ester Del Duca, Dionisio Silvaggio, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Journal of Biophotonics|September 17, 2015
Label-free and non-invasive discrimination of HaCaT and melanoma cells in a co-culture model by hyperspectral confocal reflectance microscopyFrancesca R Bertani, Elisabetta Botti, Luisa Ferrari, et al.
Drug Development Research|November 11, 2014
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerationsBarbara Marinari, Elisabetta Botti, Mauro Bavetta, et al.
Dermatology Practical & Conceptual|March 22, 2021
Usefulness of Topical Imiquimod 3.75% in Cytokeratin 7 Positive Extramammary Paget Disease of the Vulva: Towards Personalized TherapySara Mazzilli, Annunziata Dattola, Anna Angela Criscuolo, et al.
The Journal of International Medical Research|September 30, 2016
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritisMaria Sole Chimenti, Paola Triggianese, Elisabetta Botti, et al.
Journal of the American Academy of Dermatology|December 4, 2018
Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observationsRaffaele Dante Caposiena Caro, Maria Vittoria Cannizzaro, Elisabetta Botti, et al.
Italian Journal of Dermatology and Venereology|October 24, 2018
Long-term efficacy and safety of adalimumab on a severe case of hidradenitis suppurativaRaffaele D Caposiena Caro, Maria V Cannizzaro, Cosimo DI Raimondo, et al.
Immunology Letters|October 22, 2013
Genetic variations in IL6 and IL12B decreasing the risk for psoriasisAndreea Nicoleta Boca, Marina Talamonti, Marco Galluzzo, et al.
Health Science Reports|May 12, 2021
HLA-C*06:02 allele can influence clinical efficacy of certolizumab pegol?Annunziata Dattola, Elisabetta Botti, Marco Galluzzo, et al.
BMC Research Notes|December 19, 2014
Severe erytrodermic psoriasis in child twins: from clinical-pathological diagnosis to treatment of choice through genetic analyses: two case reportsElena Campione, Laura Diluvio, Alessandro Terrinoni, et al.
The Australasian Journal of Dermatology|October 11, 2020
Cutaneous mastocytosis: A dermatological perspectiveCosimo Di Raimondo, Ester Del Duca, Dionisio Silvaggio, et al.
Pageof 5